Peter Casasanto

Peter Casasanto is an executive in the life sciences industry with experience and expertise spanning both corporate and business development and sales strategy, supporting biomarker development and precision medicine. Peter joined SOPHiA GENETICS as Chief BioPharma Officer in January 2022. He started in the industry 15 years ago as a scientist at Merck in their Vaccines & Biologics group. Peter holds an MBA in pharmaceutical management from Drexel’s LeBow College of Business, a master’s degree in biomedical chemistry from Thomas Jefferson Medical School, and a bachelor of science in immunology and genomics from the University of Maryland at College Park.